Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Journal of Clinical and Experimental Hepatology|March 5, 2025
Outcomes of Living Donor Liver Transplantation in Recipients Colonized With Carbapenem-Resistant EnterobacteralesAkila Rajakumar, Prijith Ramanan, Amal F Sam, et al.
Circulation|November 1, 2000
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study InvestigatorsM T Slawsky, W S Colucci, S S Gottlieb, et al.
Circulation|February 18, 1997
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure ResearchJ N Cohn, M R Bristow, K R Chien, et al.
Journal of Cardiac Failure|October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study GroupJ N Cohn, M B Fowler, M R Bristow, et al.
Journal of Clinical and Experimental Hepatology|April 28, 2025
Living Liver Donors With Harris Platelet Syndrome Related Thrombocytopenia: A Case SeriesPrateek Gupta, Rathnavel G Kanagavelu, Amal F Sam, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|June 27, 2026
Title of the study: Corrected Count Increment as a Predictor of Early Graft Dysfunction and Mortality Following Living Donor Liver TransplantationDeepti Sachan, Amal F Sam, B Lavanya Sree, et al.
Toxicon : Official Journal of the International Society on Toxinology|April 28, 2009
Morphological and ultrastructural effects of microcystin-LR from Microcystis aeruginosa extract on a kidney cell lineE Alverca, M Andrade, E Dias, et al.
Circulation|December 1, 1996
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study GroupW S Colucci, M Packer, M R Bristow, et al.
Psychiatric Genetics|November 4, 1998
Investigation of dopamine system genes in obsessive-compulsive disorderE A Billett, M A Richter, F Sam, et al.
Circulation|December 1, 1996
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and ExerciseM Packer, W S Colucci, J D Sackner-Bernstein, et al.
Pageof 17